Copies of these filings are available online at www. This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of Designed with ongoing input from patients like you, products from LifeScan, Inc.
Visit the Acclarent Website Arrhythmias To treat patients with irregular heartbeats, hospitals and teaching institutions rely on advanced diagnostic, therapeutic and mapping tools from Biosense Webster.
We bring together cutting-edge insights, science, technology and people to encourage professionals and patients to proactively preserve and enhance sight for life. As pioneers in medical devices, we continually focus on elevating the standard of care—working to expand patient access, improve outcomes, reduce health system costs and drive value.
Endomechanical Ethicon remains a worldwide leader in the development of advanced tissue management, including surgical stapling and endocutter technologies. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship.
We create smart, people-centered healthcare to help the patients we serve recover faster and live longer and more vibrantly.
For more than a decade, Acclarent has led the field in delivering innovative technologies to ENT surgeons. Our comprehensive wound closure portfolio lets surgeons match the specific wound healing needs of each tissue type to the appropriate closure device.
The reader is cautioned not to rely on these forward-looking statements. Solutions comprise innovative, biologically based products for surgical conditions that are often difficult or expensive to manage—such as problematic bleeding. Breast Aesthetics We develop, manufacture and market innovative, science-based products for surgical and non-surgical medical procedures that allow patients to improve their quality of life.
Its singular focus is to free patients to live better lives by designing, developing and commercializing medical devices that address conditions affecting the ear, nose and throat. Biosurgery Our Ethicon portfolio of adjunctive hemostats is dedicated to aiding surgery by focusing on an array of biosurgery technologies to minimize intra- and postoperative complications.
Offering endocutters along with a full range of surgical stapling options, Ethicon provides surgeons with advanced instrumentation across the spectrum of surgical methods—all designed to support optimal patient outcomes. General Surgery In hospitals around the world, surgeons operate with confidence using trusted surgical systems and instruments designed to provide the safest and most effective treatment for a range of medical conditions.
This meaningful innovation is intended to help health care systems, governments and providers improve clinical outcomes, increase patient satisfaction and contain costs; three tenets shared by most global health care reform acts, known widely as the Triple Aim.
DePuy Synthes Companies solutions, in specialties including joint reconstruction, trauma, cranio-maxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to healthcare systems worldwide.
Trauma We are the global leader in medical devices used to treat orthopaedic trauma.Johnson & Johnson (NYSE:JNJ) said today that its medical device business paid an undisclosed amount to acquire French robot-assisted surgery company Orthotaxy.
J&J said it plans to expand the. Johnson & Johnson Medical Devices & Diagnostics Businesses Expanding Market Leadership with Innovative Products and Customer-Focused Solutions segment of Johnson & Johnson will outline plans to improve patient outcomes and expand their market leadership through innovative products, new business models and a significant.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice. MassDevice Today. Cardiovascular; Clinical Trials; Johnson & Johnson plans.
Johnson & Johnson Medical Devices Companies. the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc.
Contact Us with any questions or Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical Business. See All. At Johnson & Johnson Medical Devices Companies (JJMDC), closure portfolio lets surgeons match the specific wound healing needs of each tissue type to the appropriate closure device.
The Global Orthopaedics business of DePuy Synthes is composed of Joint Reconstruction, Trauma, Spine, Sports Medicine and Power Tools. The Johnson & Johnson Medical Devices Companies have a successful history in creating new markets, delivering breakthrough innovation and establishing strong partnerships built on a shared vision.
Our Medical Device business includes three global franchises, Ethicon (Surgery), Biosense Webster (Cardiovascular & Specialty .Download